Re:About that Hydroxychloroquine for Covid-19 trial
by DanBC on Monday March 23, 2020 @05:49PM
(#22669190)
If you're just looking at them to see if they got better you don't need an expensive test that has a 40% false negative rate.
But that's not what these doctors were doing, is it? They weren't looking at whether the patient got better or not. They were looking at viral load only.
https://twitter.com/GaetanBurgio/status/1241201751916568576
> Outcome from the study is based on viral load only and not on clinical outcome and I can see a major flaw here as clinical outcome critical.
It's difficult to due true double blind random studies in these cases because doctors are there to give everyone the best chance at recovery, not to pick half of a group to potentially do worse.
Hopefully we can ethically do well design studies on controlled groups with moderate symptoms, but until then this imperfect clinical data is very interesting.